Friday - April 17, 2026
Kirkland Represents CICC on Fosun New Medicine's Privatization of Shanghai Henlius
June 26, 2024
CHICAGO, Illinois, June 26 -- Kirkland and Ellis, a law firm, issued the following news release:

Kirkland & Ellis is advising China International Capital Corporation Hong Kong Securities Limited, financial adviser to Shanghai Fosun New Medicine Research Company Limited, a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKSE: 2196), on the proposed privatization of Shanghai Henlius Biotech, Inc. (HKSE: 2696).

The privatization, which will . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products